We are a clinical stage biopharmaceutical company developing novel therapies for the management of pain and other central nervous system, or CNS, disorders. By focusing on this therapeutic area, we are addressing significant and growing markets where current treatment options are limited or inadequate. Our product candidate portfolio includes two late-stage candidates, AXS-02 and AXS-05, which we are developing for multiple indications. We aim to become a fully integrated biopharmaceutical company that develops and commercializes differentiated therapies that expand the treatment options available to caregivers and improve the lives of patients living with pain and other CNS disorders.
| Website | http://www.coloradolifescience.com |
| Revenue | $31.5 million |
| Employees | View employees |
| Address | PO Box 273330, Fort Collins, Colorado 80527, US |
| Phone | +1 720-564-9100 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Merck & Co., Inc., Amgen, PPD, Biogen, SomaLogic, Clovis Oncology, Strata Oncology, Celyad Oncology, ZyVersa Therapeutics Inc., Otonomy, Inc +36 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular ColoradoLifeScience.com employee's phone or email?
ColoradoLifeScience.com Questions
The ColoradoLifeScience.com annual revenue was $31.5 million in 2026.
ColoradoLifeScience.com is based in Fort Collins, Colorado.
The NAICS codes for ColoradoLifeScience.com are [3254, 32541, 325, 32].
The SIC codes for ColoradoLifeScience.com are [28, 283, 2834].
